OCULAR THERAPEUTIX, INC (OCUL) Operating cash flow 2016–2025
OCULAR THERAPEUTIX, INC (OCUL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$204.9MFY2025 · since FY2016: -$34.0M → -$204.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$204.9M | -52.1% |
| FY2024 | -$134.7M | -91.8% |
| FY2023 | -$70.2M | -17.8% |
| FY2022 | -$59.6M | +9.1% |
| FY2021 | -$65.5M | -22.4% |
| FY2020 | -$53.6M | +31.0% |
| FY2019 | -$77.6M | -57.6% |
| FY2018 | -$49.2M | +2.5% |
| FY2017 | -$50.5M | -48.4% |
| FY2016 | -$34.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OCUL financial trends
OCUL RevenueOCUL Net incomeOCUL Net marginOCUL Gross profitOCUL Gross marginOCUL Operating incomeOCUL Operating marginOCUL Free cash flowOCUL Capital expendituresOCUL Return on equityOCUL Stock buybacksOCUL Dividends paidOCUL Total assetsOCUL Total liabilitiesOCUL Shareholders’ equityOCUL overview →